Although interactions between FDFT1 and its partners have been determined by the different methods such as affinity capture-MS and yeast two-hybrid (shown in Table 1), most of these interacting molecules have been not studied for their association with FDFT1 in reports focused on the hallmarks of cancer. The gene discussed is FDFT1; the disease is cancer.